Article
不良研究所 cell therapy pipeline featured in Endpoints News
Endpoints News did an exclusive interview with 不良研究所's CEO after the cell therapy pipeline announcement with an initial focus on the liver.
17.11.2023Endpoints News did an exclusive interview with 不良研究所's CEO after the cell therapy pipeline announcement with an initial focus on the liver.